Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial
about
Opioids for agitation in dementiaNMDA Receptor Function During Senescence: Implication on Cognitive PerformanceEfficacy of memantine, donepezil, or their association in moderate-severe Alzheimer's disease: a review of clinical trialsPharmacological management of behavioral symptoms associated with dementiaAssessment and management of behavioral and psychological symptoms of dementiaEffect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial.Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial.NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialTrends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study.Improving the management of behaviour that challenges associated with dementia in care homes: protocol for pharmacy-health psychology intervention feasibility study.The threat of behavioral changes in dementiaDrug Therapy for Behavioral and Psychological Symptoms of DementiaMibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.Systematic review of non-pharmacologic interventions to delay functional decline in community-dwelling patients with dementia.Treatment of Alzheimer's Disease: Current Management and Experimental Therapeutics.Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?Agitation and aggression in Alzheimer's disease: an update on pharmacological and psychosocial approaches to care.Cannabinoids in late-onset Alzheimer's disease.Efficacy and adverse effects of memantine treatment for Alzheimer's disease from randomized controlled trials.Best practice in the management of behavioural and psychological symptoms of dementia.Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease.Management of Behavioral and Psychological Symptoms of Dementia.Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.Morinda citrifolia L. (noni) and memantine attenuate periventricular tissue injury of the fourth ventricle in hydrocephalic rabbits.Behavioral management in the person with dementia.Dementia-related agitation: a review of non-pharmacological interventions and analysis of risks and benefits of pharmacotherapy.Republished: the role of amyloid β in the pathogenesis of Alzheimer's disease.Withdrawal of Antidementia Drugs in Older People: Who, When and How?Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs.Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies.Pharmacological treatments for alleviating agitation in dementia: A systematic review and network meta-analysis.Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects.Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review
P2860
Q24187950-17E3C4F6-A890-4A83-8946-10E44AE23EF8Q26770902-94E901C1-A665-43CD-B107-78996BB7D32BQ26851862-F4916D61-7E61-41E6-9A44-9397FBF517B4Q28081955-D3CCF23A-6385-4B1F-A581-7B6B30AA9BEFQ28088782-DB3140BF-41E2-4220-84F2-7AAC87874F3DQ33863623-C2676B92-5FD6-49AB-8D94-B63168A4E683Q34977377-A0449B0A-4E3A-4DB5-89B4-BE8C1048D85DQ35185368-87CE5FE7-B344-4C1A-B28F-74DEF3F7737CQ35730949-5AB8A7D8-B75A-4260-81D3-048290855BF2Q36310524-62B8830E-0C81-49BC-A48D-9ED8DBEC3D2AQ36345261-4C32270B-3555-481F-A426-8E090F3601F6Q36545982-C14C1173-0949-456E-9C2E-099C2327271CQ36732899-74DC6C3B-9853-447C-B5A0-4FE99D147E35Q36866803-338F1D37-81B9-40FB-A97A-EB1486744E46Q36925888-0275C456-BAB0-4742-A700-0A5869EE9F08Q37610213-1F9134EB-9856-4CCA-A869-D6EFA17ABE33Q38101072-D0781EDA-DC50-4A61-B805-18DE750F0077Q38149130-5764E5A3-0221-4077-85C4-5EC41F7BCF28Q38252709-90BB3BD0-EF11-44AA-B4C5-16702CD3312AQ38364828-3DBC8554-2D2A-4FED-9DD7-292F0F9530E9Q38383508-2E387A3D-122D-4F57-949A-F9D35B1B59FBQ38433654-756E1BBD-1E44-432B-BF8E-C253D304076DQ38638029-7B19BD32-FAC2-4EF7-95B6-320D0F7E2556Q38906350-98755263-6522-4338-999E-07518B1E325FQ39209888-BD7916D1-3A0D-4A26-A9C0-5BC5D5C029BCQ39657233-92F35EA9-F81E-4AB7-BFCB-B52371E29581Q42844837-BCE27815-50BB-4E6F-AD83-CE50DD273209Q45439480-C6E35C48-427B-4F79-A66F-4722DD2EC35AQ46494191-F8D6C920-84DF-4EDF-B689-30B0CCD9B77CQ46943581-2D0F8609-E4DB-414B-AEBF-AD5EC2F127AFQ48167336-9774B20B-C3DA-4257-9590-F8605F9F3361Q50044080-3536D651-7DB0-4AB6-AAE8-1CE41B16C8C6Q50326656-C2A999F3-3853-450F-B31E-3E31AFBC50C1Q51512814-1889C961-BBED-4E36-B292-700B970E366BQ53279360-0AC5BAB8-064E-4D3E-A8D1-1782571DF030Q53352590-E4C05382-E0CC-4F4E-822C-0A8EEDDBC942Q58698874-FDDA6D29-A3B9-4260-8969-152AE00F549B
P2860
Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Efficacy of memantine for agit ...... blind placebo controlled trial
@ast
Efficacy of memantine for agit ...... blind placebo controlled trial
@en
Efficacy of memantine for agit ...... blind placebo controlled trial
@nl
type
label
Efficacy of memantine for agit ...... blind placebo controlled trial
@ast
Efficacy of memantine for agit ...... blind placebo controlled trial
@en
Efficacy of memantine for agit ...... blind placebo controlled trial
@nl
prefLabel
Efficacy of memantine for agit ...... blind placebo controlled trial
@ast
Efficacy of memantine for agit ...... blind placebo controlled trial
@en
Efficacy of memantine for agit ...... blind placebo controlled trial
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Efficacy of memantine for agit ...... blind placebo controlled trial
@en
P2093
Adrian Treloar
Bjorn Henrik Auestad
Cornelius Katona
Malaz Boustani
Monica Crugel
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0035185
P407
P577
2012-05-02T00:00:00Z